By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS


Industry
Pharmaceutical






Company News
Enanta Pharmaceuticals, Inc. Announces The Initiation Of Phase 2b Clinical Trial With Regimen Containing HCV Protease Inhibitor ABT-493 9/10/2014 10:27:24 AM
Enanta Pharmaceuticals, Inc. To Present At Three Upcoming Investor Conferences 8/28/2014 12:34:51 PM
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Third Quarter Ended June 30, 2014 8/11/2014 8:36:03 AM
Enanta Pharmaceuticals, Inc.’ HCV NS5A Inhibitor EDP-239 Advances Into Combination Studies With Alisporivir (DEB025) 8/7/2014 10:32:22 AM
Enanta Pharmaceuticals, Inc. Announces European Medicines Agency Validates Marketing Authorization Applications For AbbVie (ABBV)’s Investigational, All-Oral, Interferon-Free Regimen For Genotype 1 Chronic Hepatitis C 6/17/2014 11:31:59 AM
Enanta Pharmaceuticals, Inc. Announces U.S. FDA Grants Priority Review To AbbVie (ABBV) For Investigational, All-Oral, Interferon-Free Regimen For Genotype 1 Chronic Hepatitis C 6/16/2014 10:54:07 AM
Enanta Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences 6/11/2014 6:42:08 AM
Enanta Pharmaceuticals, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/22/2014 7:46:45 AM
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Second Quarter Ended March 31, 2014 5/12/2014 7:13:11 AM
Enanta Pharmaceuticals, Inc. Announces The Appointment Of Nathaniel S. Gardiner, J.D. As Senior Vice President And General Counsel 5/12/2014 7:10:44 AM
1234567
//-->